RecruitingNCT06372444

Mechanisms of Acute Kidney Injury in Severe Infections


Sponsor

Uppsala University Hospital

Enrollment

15 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Renal perfusion and neutrophil-mediated inflammation will be assessed in the kidney in sepsis patients with acute kidney injury using positron emission tomography. For marked water will be used for renal perfusion and a newly developed PET tracer molecule (11C-GW457427) with specific binding to neutrophil elastase which provides a measure of the amount of infiltrating neutrophils in the renal parenchyma for inflammation. The study is performed in a PET-CT camera where anatomical imaging takes place at the same time as the PET examinations.


Eligibility

Min Age: 30 Years

Inclusion Criteria7

  • Patients with sepsis and AKI
  • > 30 years
  • At least AKI stage 1 according to KDIGO where the last plasma creatinine is measured within 24 hours of the examination
  • Healthy volunteers
  • > 30 years
  • No previously known kidney disease
  • Normal plasma creatinine value

Exclusion Criteria4

  • Chronic renal failure (CKD stage >3a) or dialysis
  • Instability in vital functions that makes PET-CT examination unsuitable
  • Claustrophobia or other reasons that make the patient unable to lie still during the examination.
  • Pregnancy and breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPositron emission tomography (PET)

Assessment of blood flow with marked water and assessment of neutrophil presence with neutrophil elastase tracer + CT


Locations(1)

Uppsala university hospital

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06372444


Related Trials